Trial
NCT02589340
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
Portland VA Medical Center
Condition
Parkinson's Disease
Intervention
Buspirone
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-05